Jacqueline O Leary
Gastroenterology · Dallas, TXNPI 1336121565
Payments from drug & device makers
$1,383,211in general payments, 2019–2025
Across 515 payments — averaging $2685.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols Therapeutics LLC$590K
- Bausch Health US, LLC$404K
- Madrigal Pharmaceuticals$144K
- AbbVie$92K
- Gilead$60K
- Grifols Biologicals LLC$54K
- plus $39K from 7 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols Therapeutics LLC | 47 | $590,104 |
| Bausch Health US, LLC | 204 | $403,936 |
| Madrigal Pharmaceuticals | 27 | $144,015 |
| AbbVie(2 entities) | 122 | $91,653 |
| Gilead | 63 | $60,103 |
| Grifols Biologicals LLC | 33 | $54,268 |
| Mallinckrodt Enterprises LLC | 5 | $19,232 |
| Mallinckrodt Hospital Products Inc. | 8 | $15,612 |
| Novo Nordisk AS | 1 | $2,325 |
| Intercept Pharmaceuticals, Inc. | 2 | $1,000 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $750 |
| Grifols, S.A. | 1 | $118 |
| Novo Nordisk | 1 | $94 |
How this compares
$1,383,211 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in Dallas
- John FordtranDallas$9.9M
- Parvez MantryDallas$6.4M
- Michael BrownDallas$5.5M
- Themistocles DassopoulosDallas$1.1M
- Moheb BoktorDallas$1M
- Lisa VanwagnerDallas$486K
- Rodney InfanteDallas$442K
- Eric LawitzSan Antonio$59.5M
- George DuvallTyler$17.5M
- Timothy RitterSouthlake$7.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.